logo-loader
viewLexagene Holdings Inc.

Lexagene takes big step forward by now being recognized by FDA and CDC

Lexagene Holdings (CVE: LXG-OTCQB-LXXGF) CEO and Co-Founder Dr Jack Regan joined Steve Darling from Proactive Investors Vancouver to talk about the company now being recognized by the Food and Drug Administration and the US Centre for Disease control.

Regan discussed what this means for the company moving forward and what their timeline looks like for commercialization.

Quick facts: Lexagene Holdings Inc.

Price: 0.48 CAD

TSX-V:LXG
Market: TSX-V
Market Cap: $41.13 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexagene Holdings Inc. named herein, including the promotion by the Company of Lexagene Holdings Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Lexagene adds to management team as they continue developing...

Lexagene (CVE: LXG-OTCQB: LXXGF) CEO Jack Regan joined Steve Darling from Proactive Vancouver to discuss the company adding a new member to their management team as they continue to move towards bringing their testing technology to market. Regan also gave Proactive an update on another part...

10 hours, 3 minutes ago

2 min read